Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05806216Completed

Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD)

Role: lead

NCT05675371Completed

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Role: lead

NCT03469986Completed

A Multi-site Comparison of Social Visual Engagement to Clinical Diagnosis for Autism Spectrum Disorder

Role: lead

NCT04860986Completed

A Repeatability and Reproducibility Study of the EarliPoint™ Device

Role: lead

All 4 trials loaded